DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage

被引:111
作者
Jimenez, GS
Bryntesson, F
Torres-Arzayus, MI
Priestley, A
Beeche, M
Saito, S
Sakaguchi, K
Appella, E
Jeggo, PA
Taccioli, GE
Wahl, GM
Hubank, M
机构
[1] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA
[2] Univ Sussex, Trafford Ctr, Brighton BN1 9RY, E Sussex, England
[3] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA
[4] Univ Sussex, MRC, Cell Mutat Unit, Brighton BN1 9RR, E Sussex, England
[5] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA
基金
英国惠康基金;
关键词
D O I
10.1038/21913
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Damage to DNA in the cell activates the tumour-suppressor protein p53 (ref. 1), and failure of this activation leads to genetic instability and a predisposition to cancer, It is therefore crucial to understand the signal transduction mechanisms that connect DNA damage with p53 activation. The enzyme known as DNA-dependent protein kinase (DNA-PK) has been proposed to be an essential activator of p53 (refs 2, 3), but the evidence for its involvement in this pathway is controversial(3,4). We now show that the p53 response is fully functional in primary mouse embryonic fibroblasts lacking DNA-PK: irradiation-induced DNA damage in these defective fibroblasts induces a normal response of p53 accumulation, phosphorylation of a p53 serine residue at position 15, nuclear localization and binding to DNA of p53. The upregulation of p53-target genes and cell-cycle arrest also occur normally. The DNA-PR-deficient cell line SCGR11 contains a homozygous mutation in the DNA-binding domain of p53, which may explain the defective response by p53 reported in this line(3), Our results indicate that DNA-PK activity is not required for cells to mount a p53-dependent response to DNA damage.
引用
收藏
页码:81 / 83
页数:3
相关论文
共 19 条
  • [1] The complexity of p53 modulation: emerging patterns from divergent signals
    Giaccia, AJ
    Kastan, MB
    [J]. GENES & DEVELOPMENT, 1998, 12 (19) : 2973 - 2983
  • [2] Growth retardation and leaky SCID phenotype of Ku70-deficient mice
    Gu, YS
    Seidl, KJ
    Rathbun, GA
    Zhu, CM
    Manis, JP
    vanderStoep, N
    Davidson, L
    Cheng, HL
    Sekiguchi, JM
    Frank, K
    StanhopeBaker, P
    Schlissel, MS
    Roth, DB
    Alt, FW
    [J]. IMMUNITY, 1997, 7 (05) : 653 - 665
  • [3] Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects
    Hainaut, P
    Soussi, T
    Shomer, B
    Hollstein, M
    Greenblatt, M
    Hovig, E
    Harris, CC
    Montesano, R
    [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (01) : 151 - 157
  • [4] Huang LC, 1996, CANCER RES, V56, P2940
  • [5] DNA-PK: At the cross-roads of biochemistry and genetics
    Jeggo, PA
    [J]. MUTATION RESEARCH-DNA REPAIR, 1997, 384 (01): : 1 - 14
  • [6] Jongmans W, 1996, ONCOGENE, V13, P1133
  • [7] HUMAN DNA-ACTIVATED PROTEIN-KINASE PHOSPHORYLATES SERINE-15 AND SERINE-37 IN THE AMINO-TERMINAL TRANSACTIVATION DOMAIN OF HUMAN P53
    LEESMILLER, SP
    SAKAGUCHI, K
    ULLRICH, SJ
    APPELLA, E
    ANDERSON, CW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (11) : 5041 - 5049
  • [8] p53, the cellular gatekeeper for growth and division
    Levine, AJ
    [J]. CELL, 1997, 88 (03) : 323 - 331
  • [9] A reversible, p53-dependent G(0)/G(1) cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage
    Linke, SP
    Clarkin, KC
    Di Leonardo, A
    Tsou, A
    Wahl, GM
    [J]. GENES & DEVELOPMENT, 1996, 10 (08) : 934 - 947
  • [10] How p53 binds DNA as a tetramer
    McLure, KG
    Lee, PWK
    [J]. EMBO JOURNAL, 1998, 17 (12) : 3342 - 3350